Status:
COMPLETED
Ph II Early BC Pre-Surgical Biologic Study
Lead Sponsor:
AstraZeneca
Collaborating Sponsors:
Cancer International Research Group (CIRG)
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
A pre-surgery study to assess changes that occur in human breast cancer material and normal skin after a short course of treatment with Iressa.
Eligibility Criteria
Inclusion
- Invasive breast cancer, Aged 18 years or older, Not more than 28 days from initial diagnosis
Exclusion
- Pregnant or lactating patients, Prior or current radiotherapy for breast cancer, Known allergy reaction to Iressa
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2005
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT00637026
Start Date
July 1 2003
End Date
February 1 2005
Last Update
April 23 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.